Abstract

Increased number of prostate cancer patients selecting high dose-rate interstitial brachytherapy during the COVID-19 pandemic

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call